Independent analysis of European MedTech, digital health, and AI
MedTech, Digital Health & AI in Europe — Strategy, Market Signals, and What Comes Next
Commercialization, regulation, AI, and market dynamics shaping healthcare in Europe written from an operator’s perspective.
Weekly MedTech News
Weekly breakdown of funding, regulation, product launches, and strategic moves shaping European MedTech and digital health.
-
Europe MedTech News: Waiv, Vitestro, MiniMed and EU AI Policy (Mar 9–15, 2026, #28)
The most relevant medtech news and market signals this week for commercial, digital, and strategy leaders across Europe. This week’s Europe medtech news points to a market that is becoming less patient with vague AI platform stories and more interested in deployment readiness: products that fit workflows, evidence plans that survive scrutiny, and policy moves…
-
Europe MedTech News: Xsensio funding, FARAPULSE CE mark, and UK NICE policy (Week of Mar 2-8, 2026, #27)
A week in which Swiss sensors found deep pockets, “boring” logistics became interesting, and Europe’s commercialization machine kept reminding everyone that market access is only the beginning. Weekly snapshot of MedTech and Digital Health NEWS in Europe People on the move MedTech leadership: Coloplast Coloplast named Gavin Wood as its next President and CEO, effective…
-
Europe MedTech & Digital Health Weekly Brief (Week of Feb 23–Mar 1, 2026, #26)
This week: Europe writes bigger cheques for edge AI, surgeons get sharper intra-op vision, and regulators quietly upgrade the “plumbing” that makes scale possible. People on the move Precision IO Group (Quantum Surgical + NeuWave Medical) Kurt Azarbarzin appointed CEO as the new parent company forms around Quantum’s acquisition of J&J’s NeuWave Medical. The industrial…
Get the Weekly MedTech Signal
Funding, regulation, AI, and strategic moves shaping healthcare in Europe in one sharp weekly read.
Strategic Perspectives on European MedTech
MedTech Market Intelligence
Funding, valuations, and strategic moves.
Commercialization & Go-to-Market
AI & Digital Health
About
Piotr Wrzosinski is a life sciences commercial and digital transformation leader with 20+ years of experience across pharma, MedTech, and consulting. He focuses on commercialization, omnichannel strategy, and AI-driven transformation in Europe.